biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Apparently, It Takes Gull to Be Me

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Aug 25, 2023 1:33pm

58 Views

Post# 35605676

RE:RE:RE:RE:RE:Apparently, It Takes Gull to Be Me

Boomskid wrote: I haven't started Boomskid yet. Every time I think I'm close things come up. The novels are too much fun and they may turn out to be my most consuming projects. Boomskid will be topical, which means less time and effort once it gets going.

But my novels! The people I'm meeting in them!

No, I don't think you need to worry, TT.

Think about it. You and i will be in the same business, writing fiction.

jd